The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

List includes medications for diabetes, cancer, arthritis, and more ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for ...

HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in ...

A new study shows fewer Americans negotiate prices for goods and services — including things like new cars, new homes, and ...